BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17303688)

  • 1. Preanalytic influence of sample handling on SELDI-TOF serum protein profiles.
    Timms JF; Arslan-Low E; Gentry-Maharaj A; Luo Z; T'Jampens D; Podust VN; Ford J; Fung ET; Gammerman A; Jacobs I; Menon U
    Clin Chem; 2007 Apr; 53(4):645-56. PubMed ID: 17303688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein detection in dried blood by surface-enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS).
    Dammann CE; Meyer M; Dammann O; von Neuhoff N
    Biol Neonate; 2006; 89(2):126-32. PubMed ID: 16210847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry.
    Banks RE; Stanley AJ; Cairns DA; Barrett JH; Clarke P; Thompson D; Selby PJ
    Clin Chem; 2005 Sep; 51(9):1637-49. PubMed ID: 16002455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum.
    Albrethsen J; Bøgebo R; Olsen J; Raskov H; Gammeltoft S
    Clin Chem Lab Med; 2006; 44(10):1243-52. PubMed ID: 17032137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
    Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
    Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry of the Effects of Preanalytical Variables on Serum Peptidome Profiles Following Long-Term Sample Storage.
    Tsuchida S; Satoh M; Umemura H; Sogawa K; Takiwaki M; Ishige T; Miyabayashi Y; Iwasawa Y; Kobayashi S; Beppu M; Nishimura M; Kodera Y; Matsushita K; Nomura F
    Proteomics Clin Appl; 2018 May; 12(3):e1700047. PubMed ID: 29349874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MS.
    Karatayli SC; Alagöz SG; Mizrak D; Sayki M; Ozkan M; Savaş B; Erden E; Cinar K; Idılman R; Yurdaydin C; Bozdayi AM
    Turk J Gastroenterol; 2012 Feb; 23(1):46-53. PubMed ID: 22505379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample handling for mass spectrometric proteomic investigations of human urine.
    Petri AL; Høgdall C; Christensen IJ; Simonsen AH; T'jampens D; Hellmann ML; Kjaer SK; Fung ET; Høgdall E
    Proteomics Clin Appl; 2008 Sep; 2(9):1184-93. PubMed ID: 21136916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Liu JY; Jin L; Zhao MY; Zhang X; Liu CB; Zhang YX; Li FJ; Zhou JM; Wang HJ; Li JC
    Clin Chem Lab Med; 2011 Oct; 49(10):1727-33. PubMed ID: 21671803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.
    Chung L; Moore K; Phillips L; Boyle FM; Marsh DJ; Baxter RC
    Breast Cancer Res; 2014 Jun; 16(3):R63. PubMed ID: 24935269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
    Ndao M
    Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling.
    Gast MC; van Dulken EJ; van Loenen TK; Kingma-Vegter F; Westerga J; Flohil CC; Knol JC; Jimenez CR; van Gils CH; Wessels LF; Schellens JH; Beijnen JH
    Int J Biol Markers; 2009; 24(3):130-41. PubMed ID: 19787623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.
    Papale M; Pedicillo MC; Thatcher BJ; Di Paolo S; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):205-13. PubMed ID: 17613287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions.
    Traum AZ; Wells MP; Aivado M; Libermann TA; Ramoni MF; Schachter AD
    Proteomics; 2006 Mar; 6(5):1676-80. PubMed ID: 16447157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteomic profiles of Aspergillus fumigatus and Aspergillus lentulus strains by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    Pinel C; Arlotto M; Issartel JP; Berger F; Pelloux H; Grillot R; Symoens F
    BMC Microbiol; 2011 Jul; 11():172. PubMed ID: 21798007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
    Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
    BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes.
    Chung L; Nelson AE; Ho KK; Baxter RC
    J Clin Endocrinol Metab; 2009 Aug; 94(8):3038-43. PubMed ID: 19491220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
    Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
    Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.